NGL Fine-Chem Limited Peer Comparison
NGLFINE · Healthcare · Current price ₹2,790
Peers tracked
11
NGL Fine-Chem Limited P/E
41.4x
Sector
Healthcare
NGL Fine-Chem Limited vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,758.8 | 36.9x | 4,22,273 |
| Divi's Laboratories Limited | ₹9,144.5 | 85.4x | 2,44,762 |
| Torrent Pharmaceuticals Limited | ₹4,558.9 | 86.9x | 1,73,442 |
| Zydus Lifesciences Limited | ₹1,123 | 24.3x | 1,12,149 |
| Laurus Labs Limited | ₹2,060.1 | 95.9x | 1,11,250 |
| Cipla Limited | ₹1,325.1 | 33.2x | 1,07,043 |
| Dr. Reddy's Laboratories Limited | ₹1,233 | 29.9x | 1,02,815 |
| Aurobindo Pharma Limited | ₹1,666.9 | 25.9x | 95,513 |
| Mankind Pharma Limited | ₹2,275.5 | 44.9x | 93,968 |
| Lupin Limited | ₹1,961.6 | 17.1x | 89,437 |
| NGL Fine-Chem Limited | ₹2,784.6 | 43.6x | 1,736 |
NGL Fine-Chem Limited versus its peers
NGL Fine-Chem Limited operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 41.4x may be cheap in one industry and expensive in another.
More on NGL Fine-Chem Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.